AB OVO AD NOVO Co., Ltd. is founded on our collective expertise in redox quantum chemistry and physics, encompassing over 100 years of cumulative research and development experience.

We utilize advanced AI platform technologies, including GNoMe (Google DeepMind), to validate and optimize the functionality and performance of our solutions.

Moreover, we have developed a proprietary AI platform dedicated specifically to drug discovery.